TickerFactsScreenerDevelopers

Lineage Cell Therapeutics, Inc. (LCTX) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2010: $27.7K2011: $79.4K2012: $434.3K2013: $793.0K2014: $837.0K2015: $1.11M2016: $358.0K2017: $168.0K2018: $302.0K2019: $412.0K2020: $385.0K2021: $1.43M2022: $728.0K2023: $671.0K2024: $334.0K$334.0K
2010Cost of Revenue (USD)2024
Fiscal YearCost of RevenueChange YoY
2024$334.0K-50.2%
2023$671.0K-7.8%
2022$728.0K-48.9%
2021$1.43M+270.4%
2020$385.0K-6.6%
2019$412.0K+36.4%
2018$302.0K+79.8%
2017$168.0K-53.1%
2016$358.0K-67.7%
2015$1.11M+32.3%
2014$837.0K+5.5%
2013$793.0K+82.6%
2012$434.3K+447.0%
2011$79.4K+186.4%
2010$27.7K—